Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

XeominBLA125360

Ask about this product

Xeomin is a Botulinum toxin type A product (Drug), registered by MERZ PHARMS. Linked registrations: US BLA125360, Korea 200904004. Data as of 2026-10-19.

  • Regulatory classBotulinum toxin type A · Drug
  • HolderMERZ PHARMS
  • JurisdictionsUS · KR
  • Updated2026-10-19 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

Xeomin

Product
Regulatory class
Drug
Category
Botulinum toxin type A
US · FDA BLA
BLA125360
Korea · MFDS drug licence
200904004
Registrant
MERZ PHARMS
First approval
Not obtained from an official source
Checked against official page
Not yet checked field by field against the live official page

Public: fields from the registration record.Registrant and dates are from BLA125360; 2 registrations linked.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

No data yet

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

0

No data yet

    Sources

    2